Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy of low-dose iloprost and blood pressure target after cardiac arrest
2014-002998-11Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Sep 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of iloprost in cardiac arrest (SCA), sponsored by Rigshospitalet. Primary endpoint: Change in biomarkers indicative of endothelial activation and damage. Started Sep 2014; status: completed.
02
Drugs
iloprost
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on 2014-002998-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002998-11.